A rare case of septic pulmonary embolism in co-existence with infective endocarditis and COVID-19-Reference-Cited by-同舟云学术

A rare case of septic pulmonary embolism in co-existence with infective endocarditis and COVID-19

Published:2022-10 Issue:10 Volume:17 Page:711-716
ISSN:1746-0794
Container-title:Future Virology
language:en
Short-container-title:Future Virology

Author:

Ozdemir Yusuf Emre¹^ORCID,Demir Adile Sevde¹^ORCID,Ozdemir Meryem Sahin²^ORCID,Mavi Busra³^ORCID,Ozen Can⁴^ORCID,Karaosmanoglu Hayat Kumbasar¹^ORCID

Affiliation:

1. Department of Infectious Diseases & Clinical Microbiology, Bakirkoy Dr Sadi Konuk Training Research Hospital, Istanbul, 34140, Turkey

2. Department of Infectious Diseases & Clinical Microbiology, Istanbul University – Cerrahpasa, Cerrahpasa Faculty of Medicine, Istanbul, 34093, Turkey,

3. Department of Cardiology, Bakirkoy Dr Sadi Konuk Training Research Hospital, Istanbul, 34140, Turkey

4. Department of Cardiovascular Surgery, Bakirkoy Dr Sadi Konuk Training Research Hospital, Istanbul, 34140, Turkey

Abstract

Infective endocarditis (IE) symptoms including fever, fatigue, dyspnea and myalgia are similar in COVID-19 findings. Therefore, the diagnosis of IE may be missed in patients with COVID-19. Co-existence with IE in COVID-19 is rarely reported. However, to our knowledge, only one case of septic pulmonary embolism in COVID-19 and IE was reported. Here, we describe a case of septic embolism due to tricuspid endocarditis caused by intravenous drug use in patients with COVID-19. In this fatal case, the use of prophylactic anticoagulants due to COVID-19 probably caused the tendency to hemorrhagic cerebrovascular complications. Our report emphasizes the complexity of anticoagulant prophylaxis in patients with COVID-19 which may cause hypercoagulopathy in co-existence with IE.

Publisher

Future Medicine Ltd

Subject

Virology

Link

https://www.futuremedicine.com/doi/pdf/10.2217/fvl-2022-0029

Reference18 articles.

1. Infective Endocarditis and COVID 19: A Systematic Review

2. Cardiac complications in patients hospitalised with COVID-19

3. Epidemiological, Clinical, and Prognostic Features of Infective Endocarditis: A Retrospective Study with 90 Episodes

4. Proposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis

5. Republic of Turkey Ministry of Health COVID-19 (SARS-CoV-2 infection) Anticytokine-anti-inflammatory therapies, coagulopathy management. Republic of Turkey Ministry of Health, General Directorate of Public Health Guideline, Scientific Committee Study (2021). https://covid19.saglik.gov.tr/Eklenti/39296/0/covid-19rehberiantisitokin-antiinflamatuartedavilerkoagulopatiyonetimipdf.pdfntiinflamatuartedavilerkoagulopatiyonetimipdf.pdf